NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc. Stock News
$0.565
-0.0355 (-5.91%)
At Close: Mar 28, 2024
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 14)
10X Genomics Inc (NASDAQ:...
PlusDental expandiert nach Frankreich und ist Deutschlands Testsieger
12:00am, Thursday, 08'th Oct 2020
Plusdental expandiert im Rahmen seines Wachstumskurses in den französischen Markt und ist nun in insgesamt sechs europäischen Ländern vertreten. Das B
Sabio Group erweitert mit der Übernahme von Anana ihre Kompetenzen in Kundenerfahrung
12:00am, Tuesday, 06'th Oct 2020
Sabio Group hat den Spezialisten für Kundenerfahrungslösungen Anana erworben. Die Übernahme unterstützt das Ziel von Sabio, zum führenden Anbieter auf
The Global TIC Market will grow by USD 4.43 bn during 2020-2024
Team Gleason is collaborating with Boston Children’s Hospital’s ALS Augmentative Communication Program to provide voice banking and message banking.
16,310 Shares in Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Acquired by American International Group Inc.
04:46am, Thursday, 24'th Sep 2020
American International Group Inc. purchased a new position in Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) during the 2nd quarter, HoldingsChannel reports. The firm purchased 16,310 shares of the bi
Food Safety Testing Market by Contaminant, Technology, and Food Tested - Global Forecast to 2027 - ResearchAndMarkets.com
12:00am, Wednesday, 16'th Sep 2020
The
Everbridge, Inc. (NASDAQ: EVBG), der weltweit führende Anbieter im Bereich Critical Event Management (CEM), teilte heute mit, dass das Programm des vi
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today the publication of a manuscript titled, "Effects of M
Arizona Metals Corp. (TSX.V:AMC, OTCQB:AZMCF) (the “Company” or “Arizona Metals”) is pleased to announce the first drill hole from its recently comple
We're Keeping An Eye On Brainstorm Cell Therapeutics' (NASDAQ:BCLI) Cash Burn Rate
01:03pm, Monday, 10'th Aug 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
BrainStorm to Present at the 40th Annual Canaccord Genuity Growth Conference
11:30am, Monday, 10'th Aug 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced Ralph Kern, MD, MHSc, President and Chief Medical Off
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q2 2020 Results - Earnings Call Transcript
04:25am, Monday, 10'th Aug 2020
Evogene Ltd. (NASDAQ:EVGN) Q2 2020 Earnings Conference Call August 5, 2020 09:00 ET Company Participants Ofer Haviv - Chief Executive Officer Dorit Kreiner - Chief Financial Officer Gadi Ben Nissim -
BCLI: Phase 3 ALS Data Expected by the End of November 2020…
09:50am, Friday, 07'th Aug 2020
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Topline Data from Phase 3 ALS Trial Before End of November 2020 BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) is c
BrainStorm Announces Financial Results for the Second Quarter of 2020 and Provides a Corporate Update
11:00am, Wednesday, 05'th Aug 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the second quarter and first half ende